{
  "drug_name": "Apixaban",
  "url": "https://wikem.org/wiki/Apixaban",
  "scraped_at": "2026-01-10T07:47:59.880654",
  "sections": {
    "Administration": {
      "text": "Type:\nAnticoagulant\nDosage Forms: tablet\nDosage Strengths: 2.5mg, 5mg\nRoutes of Administration: Oral\nCommon Trade Names: Eliquis",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Anticoagulant",
          "url": "https://wikem.org/wiki/Anticoagulant"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Pulmonary_embolism,_DVT": {
          "text": "10mg PO twice daily x 7 days, then 5mg BID",
          "tables": []
        },
        "Stroke_prevention_in_afib": {
          "text": "5mg PO BID. Reduce the dose to 2.5 mg PO BID if patient has any 2 of the following: Age ≥80 years, body weight ≤60 kg, or serum creatinine ≥1.5 mg/dL.",
          "tables": []
        },
        "Post-op_DVT_prophylaxis_after_hip_or_knee_arthroplasty": {
          "text": "2.5mg BID",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pulmonary_embolism,_DVT": {
      "text": "10mg PO twice daily x 7 days, then 5mg BID",
      "subsections": {
        "Stroke_prevention_in_afib": {
          "text": "5mg PO BID. Reduce the dose to 2.5 mg PO BID if patient has any 2 of the following: Age ≥80 years, body weight ≤60 kg, or serum creatinine ≥1.5 mg/dL.",
          "tables": []
        },
        "Post-op_DVT_prophylaxis_after_hip_or_knee_arthroplasty": {
          "text": "2.5mg BID",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Stroke_prevention_in_afib": {
      "text": "5mg PO BID. Reduce the dose to 2.5 mg PO BID if patient has any 2 of the following: Age ≥80 years, body weight ≤60 kg, or serum creatinine ≥1.5 mg/dL.",
      "subsections": {
        "Post-op_DVT_prophylaxis_after_hip_or_knee_arthroplasty": {
          "text": "2.5mg BID",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Post-op_DVT_prophylaxis_after_hip_or_knee_arthroplasty": {
      "text": "2.5mg BID",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Safety/efficacy not established",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: B\nLactation risk\n: Infant risk cannot be ruled out\nRenal dosing: No adjustment for DVT/PE treatment. Afib: 2.5mg BID if creatinine >1.5\nHepatic dosing: No adjustment for mild impairment. Not recommended if severe impairment.\nDecrease dose if concomitant use of CYP3A4 and P-gp efflux dual inhibitors",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nActive bleeding",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Major bleeding (GI, muscular, epidural, intracranial, conjunctival, urinary, intraoperative)\nBleeding, severe\nAndexanet alfa\nLFT abnormalities",
          "tables": []
        },
        "Common": {
          "text": "Easy bruising, hematoma, gingival bleeding, menorrhagia, epistaxis",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Bleeding, severe",
          "url": "https://wikem.org/wiki/Anticoagulant_reversal_for_life-threatening_bleeds"
        },
        {
          "text": "Andexanet alfa",
          "url": "https://wikem.org/wiki/Andexanet_alfa"
        }
      ]
    },
    "Serious": {
      "text": "Major bleeding (GI, muscular, epidural, intracranial, conjunctival, urinary, intraoperative)\nBleeding, severe\nAndexanet alfa\nLFT abnormalities",
      "subsections": {
        "Common": {
          "text": "Easy bruising, hematoma, gingival bleeding, menorrhagia, epistaxis",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Bleeding, severe",
          "url": "https://wikem.org/wiki/Anticoagulant_reversal_for_life-threatening_bleeds"
        },
        {
          "text": "Andexanet alfa",
          "url": "https://wikem.org/wiki/Andexanet_alfa"
        }
      ]
    },
    "Common": {
      "text": "Easy bruising, hematoma, gingival bleeding, menorrhagia, epistaxis",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 7-16 hours\nMetabolism: Hepatic, mainly CYP3A4\nExcretion: 25% in urine and feces as metabolites; renal excretion accounts for 27%T of total clearance; biliary and direct intestinal excretion contributes to elimination in feces",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Reversible factor Xa inhibitor→ decreased thrombin synthesis",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Andexanet alfa\nAnticoagulant reversal for life-threatening bleeds\nProcedures in patients with coagulopathies\nPE\nDVT",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Andexanet alfa",
          "url": "https://wikem.org/wiki/Andexanet_alfa"
        },
        {
          "text": "Anticoagulant reversal for life-threatening bleeds",
          "url": "https://wikem.org/wiki/Anticoagulant_reversal_for_life-threatening_bleeds"
        },
        {
          "text": "Procedures in patients with coagulopathies",
          "url": "https://wikem.org/wiki/Procedures_in_patients_with_coagulopathies"
        },
        {
          "text": "PE",
          "url": "https://wikem.org/wiki/PE"
        },
        {
          "text": "DVT",
          "url": "https://wikem.org/wiki/DVT"
        }
      ]
    }
  }
}